When should you bring a Quantitative Clinical Pharmacologist into your program?

Most companies bring in a Quantitative Clinical Pharmacologist too late. This article explains why the non-clinical phase is the critical window for PKPD modelling and clinical pharmacology expertise, and how early investment in human dose prediction shapes formulation, toxicology, candidate selection, and regulatory strategy.